Frontiers in oncology · 2026
Construction and exploratory validation of a digital pathology prognostic model for stage II-III colorectal cancer based on contrastive learning and attention mechanisms.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lu Yizhan, Qu Zhifeng, Sun Chongbao, Li Bo, Bai Xiaoyang, Zhao Qingqing, Zhang Wenxin, Zhao Yandong, Cao Wuteng, Zhou Xuezhi
Аннотация
INTRODUCTION: Although TNM staging is the standard framework for prognostic assessment in colorectal cancer (CRC), patients within the same stage can have heterogeneous outcomes. This study aimed to extract tumor-tissue features from whole-slide images (WSIs), develop an image-derived prognostic model for stage II-III CRC, and conduct an exploratory evaluation of its performance.
METHODS: A transfer-learning tissue classifier was used to identify tumor regions in CRC WSIs. Self-supervised contrastive learning was used to extract tumor features, which were summarized by patient-level K-Means clustering. An attention-based survival model generated a locked image-derived Risk Score. The actual analyzed population comprised 335 patients with locally advanced CRC: 318 patients recorded as stage III and 17 patients with T4N0 disease (high-risk stage II by AJCC eighth-edition anatomic staging). The 265-patient TCGA cohort was randomly divided 8:2 into a training set and an internal holdout set; 70 SAHSYU patients formed a single-center exploratory cohort. Discrimination was quantified with patient-level bootstrap confidence intervals. Cox regression, Kaplan-Meier analysis, one-year calibration, and exploratory decision-curve analysis were performed. A sensitivity analysis excluded all N0 patients without retraining or changing the locked Risk Score.
RESULTS: The C-index was 0.704 (95% bootstrap CI 0.637-0.768) in training, 0.663 (0.544-0.776) in the internal holdout set, and 0.706 (0.533-0.859) in SAHSYU. Per one training-set standard deviation, the Risk Score was associated with PFS internally (HR 1.688, 95% CI 1.080-2.640; Wald p=0.022) and exploratorily in SAHSYU (HR 6.010, 95% CI 1.170-30.877; p=0.032). In the sensitivity analysis excluding all N0 records without retraining, the C-index remained 0.647 internally and 0.705 in SAHSYU; fixed-threshold log-rank p values were 0.014 and 0.027, respectively.
CONCLUSION: The image-derived Risk Score showed preliminary PFS discrimination and risk-stratification potential in stage II-III CRC. These findings require validation in larger multicenter cohorts with more events, longer follow-up, formal calibration, and clinical-utility assessment before treatment decisions can be informed.
METHODS: A transfer-learning tissue classifier was used to identify tumor regions in CRC WSIs. Self-supervised contrastive learning was used to extract tumor features, which were summarized by patient-level K-Means clustering. An attention-based survival model generated a locked image-derived Risk Score. The actual analyzed population comprised 335 patients with locally advanced CRC: 318 patients recorded as stage III and 17 patients with T4N0 disease (high-risk stage II by AJCC eighth-edition anatomic staging). The 265-patient TCGA cohort was randomly divided 8:2 into a training set and an internal holdout set; 70 SAHSYU patients formed a single-center exploratory cohort. Discrimination was quantified with patient-level bootstrap confidence intervals. Cox regression, Kaplan-Meier analysis, one-year calibration, and exploratory decision-curve analysis were performed. A sensitivity analysis excluded all N0 patients without retraining or changing the locked Risk Score.
RESULTS: The C-index was 0.704 (95% bootstrap CI 0.637-0.768) in training, 0.663 (0.544-0.776) in the internal holdout set, and 0.706 (0.533-0.859) in SAHSYU. Per one training-set standard deviation, the Risk Score was associated with PFS internally (HR 1.688, 95% CI 1.080-2.640; Wald p=0.022) and exploratorily in SAHSYU (HR 6.010, 95% CI 1.170-30.877; p=0.032). In the sensitivity analysis excluding all N0 records without retraining, the C-index remained 0.647 internally and 0.705 in SAHSYU; fixed-threshold log-rank p values were 0.014 and 0.027, respectively.
CONCLUSION: The image-derived Risk Score showed preliminary PFS discrimination and risk-stratification potential in stage II-III CRC. These findings require validation in larger multicenter cohorts with more events, longer follow-up, formal calibration, and clinical-utility assessment before treatment decisions can be informed.